NASDAQ : PFSA

Profusa, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 0.7709 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 466.89K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Details

NameProfusa, Inc.
SectorHealthcare
IndustryMedical Devices
Employees15
Founded2009
CeoJack Stover
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS74319X4051
Cusip74319X405
Cik0001859807
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Jack E. Stover CPAChief Executive Officer and Executive Chairman
Dr. Chung-Bin Hwang Ph.D.President
Fred S. KnechtelChief Financial Officer
William McMillanCo-founder, Chief Scientific Officer and Head of Research
David IckeHead of Digital Health Business
Sean GivensHead of Government Business

Contact

Address626 Bancroft Way, Suite A, Berkeley, California 94710, United States
Phone925 997 6925
Websitehttps://profusa.com